Calderoli H, Koehl C, Abecassis J, Schoenahl C, Meyer C, Hollender L F
Pathol Biol (Paris). 1978 Sep;26(6):359-60.
The authors report on their experience of the beta2-microglobulin dosage in cancerous diseases and note an increase of its rate in 47% of the cases. A comparative study with certain benign diseases of the digestive tract shows that this dosage proves to be interesting.
作者报告了他们在癌症疾病中检测β2-微球蛋白剂量的经验,并指出在47%的病例中其水平有所升高。一项针对某些消化道良性疾病的对比研究表明,这种剂量检测结果很有意义。